This 4-1BB aptamer-raptor siRNA conjugate was superior to systemic rapamycin in terms of protective anti-tumour immunity, whilst its specificity for activated 4-1BBhi CD8+ supports the formation of memory cells whilst leaving 4-1BBlo T-cells to induce effector responses [210]. This evidence concerns the gene CD8A and neoplasm.